NCT05361668 2025-10-31
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Crinetics Pharmaceuticals Inc.
Phase 2 Active not recruiting
Crinetics Pharmaceuticals Inc.
Big Ten Cancer Research Consortium
University of Kentucky
Camurus AB